Owner of Charles City drug company sold
BPC Staff Aug 9, 2019 | 8:22 pm
<1 min read time71 wordsAll Latest News, Health & Wellness, Iowa News, Manufacturing & Logistics
Radio Iowa: One of the nation’s leading drug molecule companies with a facility in northeast Iowa is being bought by an international investment firm. Cambrex Corp. announced Wednesday it has signed an agreement worth $2.4 billion with Permira, a private equity firm with offices in London, Tokyo, Hong Kong and New York. Cambrex owns a 45-acre site in Charles City employing 400 people and completed a $24 million expansion in April.
Facebook Notice for EU! You need to login to view and post FB Comments!